Atara Biotherapeutics
ATRA
$0.71
Share price
16.39%
Change (1 day)
-66.19%
Change (1 year)
Categories
P/S ratio for Atara Biotherapeutics (ATRA)
P/S ratio as of May 2024 (TTM): 9.97
According to Atara Biotherapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.97263. At the end of 2023 the company had a P/S ratio of 6.10.
P/S ratio history for Atara Biotherapeutics from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 6.10 | 24.54% |
| 2022 | 4.90 | -93.11% |
| 2021 | 71.0 | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | 30.3 | 204.16% | 🇺🇸 USA |
 Agenus
AGEN | 1.44 | -85.59% | 🇺🇸 USA |
 Affimed
AFMD | 8.77 | -12.05% | 🇩🇪 Germany |